Gastrointestinal disease is characterized by gastrointestinal dysfunction with dysbiosis of the
microbiome. Probiotics may act as biological agents in treating gastrointestinal diseases …

The emergence of antibiotic-resistant bacterial strains is a source of public health concern
across the globe. As the discovery of new conventional antibiotics has stalled significantly …

Antibiotic treatments have detrimental effects on the microbiome and lead to antibiotic
resistance. To develop a phage therapy against a diverse range of clinically relevant …

The clinical impact of infections due to extended-spectrum β-lactamase (ESBL)-and/or
carbapenemase-producing Enterobacterales (Ent) has reached dramatic levels worldwide …

With the construction of the International Space Station, humans have been continuously
living and working in space for 22 years. Microbial studies in space and other extreme …

Genetic interventions on microbiomes, for clinical or biotechnological purposes, remain
challenging. Conjugation-based delivery of genetic cargo is still unspecific and limited by …

Genetically engineered microbes, especially Escherichia coli, have been widely used in the
biosynthesis of proteins and metabolites for medical and industrial applications. As a …

Microbes naturally coexist in complex, multistrain communities. However, extracting
individual microbes from and specifically manipulating the composition of these consortia …

The gut microbiota is composed of bacteria, archaea, phages, and protozoa. It is now well
known that their mutual interactions and metabolism influence host organism …

Liver disease has become a leading cause of death, particularly in the West, where it is
attributed to more than two million deaths annually. The correlation between gut microbiota …